Skip to content
Methodology
All entries for: AlzeCure Pharma AB
July 14, 2025
AlzeCure Pharma AB
Orphan Drug Designation
FDA orphan drug designation: treatment of erythromelalgia
Disease Area:
Rare Diseases
Source
Scroll to Top
